The Journal of Immunology, Vol 157, Issue 8 3480-3490, Copyright © 1996 by American Association of Immunologists

ARTICLES

Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules

J Sidney, S Southwood, MF del Guercio, HM Grey, RW Chesnut, RT Kubo and A Sette
Cytel Corporation, San Diego, CA 92121, USA.

The HLA-B7-like binding supertype includes several different HLA-B molecules. Herein, the primary and secondary anchor specificities of the five most common HLA-B7-like molecules (B*0702, B*3501, B51, B*5301, and B*5401) were defined by the use of molecular binding assays, analogue peptides, and large sets of peptides corresponding to naturally occurring sequences. All five B7-like molecules analyzed preferentially bound 9-mers, with a stringent requirement for proline in position 2, while a variety of hydrophobic or aromatic residues were well tolerated at the C-terminal anchor position. Although most peptides bound in an allele-specific fashion, approximately 20% of the binders identified were degenerate and bound at least three of the five B7-like molecules analyzed with affinities of 500 nM or less. It was also noted that, in general, peptides that bind with high affinity to any given one B7-like molecule were also most frequently capable of degenerate binding. Prominent roles for secondary anchors in positions 1 and 3 were observed for most B7-like molecules, and secondary anchor motifs were utilized to derive an HLA-B7-like supermotif. The validity of this B7-like supermotif was tested by a blind prediction set. Finally, the B7-like supermotif was utilized to derive a general strategy for rationally engineering peptide analogues of naturally occurring sequences with greatly increased binding affinity and degeneracy. Such engineered supermotif binding peptides may be of significant utility in the development of peptide-based vaccines against chronic viral diseases and cancer.

This article has been cited by other articles:

				E. Depla, A. Van der Aa, B. D. Livingston, C. Crimi, K. Allosery, V. De Brabandere, J. Krakover, S. Murthy, M. Huang, S. Power, et al. Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections J. Virol., January 1, 2008; 82(1): 435 - 450. [Abstract] [Full Text] [PDF]

				T. Hertz and C. Yanover Identifying HLA supertypes by learning distance functions Bioinformatics, January 15, 2007; 23(2): e148 - e155. [Abstract] [Full Text] [PDF]

				X. Cortez-Gonzalez, J. Sidney, O. Adotevi, A. Sette, F. Millard, F. Lemonnier, P. Langlade-Demoyen, and M. Zanetti Immunogenic HLA-B7-restricted peptides of hTRT Int. Immunol., December 1, 2006; 18(12): 1707 - 1718. [Abstract] [Full Text] [PDF]

				P. Donnes and O. Kohlbacher SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res., July 1, 2006; 34(Web Server issue): W194 - W197. [Abstract] [Full Text] [PDF]

				O. Adotevi, K. Mollier, C. Neuveut, S. Cardinaud, E. Boulanger, B. Mignen, W.-H. Fridman, M. Zanetti, P. Charneau, E. Tartour, et al. Immunogenic HLA-B*0702-Restricted Epitopes Derived from Human Telomerase Reverse Transcriptase That Elicit Antitumor Cytotoxic T-Cell Responses. Clin. Cancer Res., May 15, 2006; 12(10): 3158 - 3167. [Abstract] [Full Text] [PDF]

				V. Pasquetto, H.-H. Bui, R. Giannino, F. Mirza, J. Sidney, C. Oseroff, D. C. Tscharke, K. Irvine, J. R. Bennink, B. Peters, et al. HLA-A*0201, HLA-A*1101, and HLA-B*0702 Transgenic Mice Recognize Numerous Poxvirus Determinants from a Wide Variety of Viral Gene Products J. Immunol., October 15, 2005; 175(8): 5504 - 5515. [Abstract] [Full Text] [PDF]

				L. M. Staska, C. J. Davies, W. C. Brown, T. C. McGuire, C. E. Suarez, J. Y. Park, B. A. Mathison, J. R. Abbott, and T. V. Baszler Identification of Vaccine Candidate Peptides in the NcSRS2 Surface Protein of Neospora caninum by Using CD4+ Cytotoxic T Lymphocytes and Gamma Interferon-Secreting T Lymphocytes of Infected Holstein Cattle Infect. Immun., March 1, 2005; 73(3): 1321 - 1329. [Abstract] [Full Text] [PDF]

				J. T. Loffredo, J. Sidney, C. Wojewoda, E. Dodds, M. R. Reynolds, G. Napoe, B. R. Mothe, D. H. O'Connor, N. A. Wilson, D. I. Watkins, et al. Identification of Seventeen New Simian Immunodeficiency Virus-Derived CD8+ T Cell Epitopes Restricted by the High Frequency Molecule, Mamu-A*02, and Potential Escape from CTL Recognition J. Immunol., October 15, 2004; 173(8): 5064 - 5076. [Abstract] [Full Text] [PDF]

				J. Sidney, S. Southwood, V. Pasquetto, and A. Sette Simultaneous Prediction of Binding Capacity for Multiple Molecules of the HLA B44 Supertype J. Immunol., December 1, 2003; 171(11): 5964 - 5974. [Abstract] [Full Text] [PDF]

				T. C. McGuire, S. R. Leib, R. H. Mealey, D. G. Fraser, and D. J. Prieur Presentation and Binding Affinity of Equine Infectious Anemia Virus CTL Envelope and Matrix Protein Epitopes by an Expressed Equine Classical MHC Class I Molecule J. Immunol., August 15, 2003; 171(4): 1984 - 1993. [Abstract] [Full Text] [PDF]

				B. R. Mothe, J. Sidney, J. L. Dzuris, M. E. Liebl, S. Fuenger, D. I. Watkins, and A. Sette Characterization of the Peptide-Binding Specificity of Mamu-B*17 and Identification of Mamu-B*17-Restricted Epitopes Derived from Simian Immunodeficiency Virus Proteins J. Immunol., July 1, 2002; 169(1): 210 - 219. [Abstract] [Full Text] [PDF]

				E. Mizukoshi, M. Nascimbeni, J. B. Blaustein, K. Mihalik, C. M. Rice, T. J. Liang, S. M. Feinstone, and B. Rehermann Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies J. Virol., May 13, 2002; 76(12): 6093 - 6103. [Abstract] [Full Text] [PDF]

				H. Kita, Z.-X. Lian, J. Van de Water, X.-S. He, S. Matsumura, M. Kaplan, V. Luketic, R. L. Coppel, A. A. Ansari, and M. E. Gershwin Identification of HLA-A2-restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis: T Cell Activation Is Augmented by Immune Complexes Cross-Presented by Dendritic Cells J. Exp. Med., January 7, 2002; 195(1): 113 - 123. [Abstract] [Full Text] [PDF]

				E. Keogh, J. Fikes, S. Southwood, E. Celis, R. Chesnut, and A. Sette Identification of New Epitopes from Four Different Tumor-Associated Antigens: Recognition of Naturally Processed Epitopes Correlates with HLA-A*0201-Binding Affinity J. Immunol., July 15, 2001; 167(2): 787 - 796. [Abstract] [Full Text] [PDF]

				R. Thimme, K.-M. Chang, J. Pemberton, A. Sette, and F. V. Chisari Degenerate Immunogenicity of an HLA-A2-Restricted Hepatitis B Virus Nucleocapsid Cytotoxic T-Lymphocyte Epitope That Is Also Presented by HLA-B51 J. Virol., April 15, 2001; 75(8): 3984 - 3987. [Abstract] [Full Text]

				J. Sidney, J. L. Dzuris, M. J. Newman, R. P. Johnson, K. Amitinder, C. M. Walker, E. Appella, B. Mothe, D. I. Watkins, and A. Sette Definition of the Mamu A*01 Peptide Binding Specificity: Application to the Identification of Wild-Type and Optimized Ligands from Simian Immunodeficiency Virus Regulatory Proteins J. Immunol., December 1, 2000; 165(11): 6387 - 6399. [Abstract] [Full Text] [PDF]

				J. Lu and E. Celis Use of Two Predictive Algorithms of the World Wide Web for the Identification of Tumor-reactive T-Cell Epitopes Cancer Res., September 1, 2000; 60(18): 5223 - 5227. [Abstract] [Full Text]

				C. M. Hay, D. J. Ruhl, N. O. Basgoz, C. C. Wilson, J. M. Billingsley, M. P. DePasquale, R. T. D'Aquila, S. M. Wolinsky, J. M. Crawford, D. C. Montefiori, et al. Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection J. Virol., July 1, 1999; 73(7): 5509 - 5519. [Abstract] [Full Text]

				P. Scognamiglio, D. Accapezzato, M. A. Casciaro, A. Cacciani, M. Artini, G. Bruno, M. L. Chircu, J. Sidney, S. Southwood, S. Abrignani, et al. Presence of Effector CD8+ T Cells in Hepatitis C Virus-Exposed Healthy Seronegative Donors J. Immunol., June 1, 1999; 162(11): 6681 - 6689. [Abstract] [Full Text] [PDF]

				K.-M. Chang, N. H. Gruener, S. Southwood, J. Sidney, G. R. Pape, F. V. Chisari, and A. Sette Identification of HLA-A3 and -B7-Restricted CTL Response to Hepatitis C Virus in Patients with Acute and Chronic Hepatitis C J. Immunol., January 15, 1999; 162(2): 1156 - 1164. [Abstract] [Full Text] [PDF]

				M. J. Shields, R. Kubota, W. Hodgson, S. Jacobson, W. E. Biddison, and R. K. Ribaudo The Effect of Human beta 2-Microglobulin on Major Histocompatibility Complex I Peptide Loading and the Engineering of a High Affinity Variant. IMPLICATIONS FOR PEPTIDE-BASED VACCINES J. Biol. Chem., October 23, 1998; 273(43): 28010 - 28018. [Abstract] [Full Text] [PDF]

				R. Bertoni, A. Sette, J. Sidney, L. G. Guidotti, M. Shapiro, R. Purcell, and F. V. Chisari Human Class I Supertypes and CTL Repertoires Extend to Chimpanzees J. Immunol., October 15, 1998; 161(8): 4447 - 4455. [Abstract] [Full Text] [PDF]

				T. M. Allen, J. Sidney, M.-F. del Guercio, R. L. Glickman, G. L. Lensmeyer, D. A. Wiebe, R. DeMars, C. D. Pauza, R. P. Johnson, A. Sette, et al. Characterization of the Peptide Binding Motif of a Rhesus MHC Class I Molecule (Mamu-A*01) That Binds an Immunodominant CTL Epitope from Simian Immunodeficiency Virus J. Immunol., June 15, 1998; 160(12): 6062 - 6071. [Abstract] [Full Text] [PDF]

				S. Southwood, J. Sidney, A. Kondo, M.-F. del Guercio, E. Appella, S. Hoffman, R. T. Kubo, R. W. Chesnut, H. M. Grey, and A. Sette Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires J. Immunol., April 1, 1998; 160(7): 3363 - 3373. [Abstract] [Full Text] [PDF]